Medical Cannabis Pre-roll Market

The North American medical cannabis pre-roll market has experienced significant growth in recent years, driven by consumer preferences for convenience and ready-to-use products. Between January 2023 and June 2024, pre-roll sales in the United States surpassed $4.1 billion, with over 394 million units sold during this period.

This surge in sales is accompanied by a notable increase in market share. In January 2023, pre-rolls held a 13.2% share of the cannabis market, which expanded to 15.9% by June 2024. Concurrently, the average price per pre-roll decreased from $7.80 in January 2023 to $6.50 in June 2024, a reduction of approximately 16.7%.

A significant contributor to this growth is the rising popularity of infused pre-rolls, which combine cannabis flower with concentrates to enhance potency and flavor. From January 2023 to June 2024, the connoisseur/infused segment generated over $1.75 billion in sales, surpassing the $1.64 billion from hybrid single-strain pre-rolls.

These premium products command higher price points, with infused pre-rolls averaging $10.46 per unit, nearly double the $5.40 average for standard pre-rolls since 2019.

Demographic trends indicate that millennials, aged 28-43, are the primary consumers in this market, accounting for 45% of pre-roll purchases.

Additionally, multi-pack pre-rolls have gained popularity, growing from 27.7% of the market in 2018 to 47.62% in 2023, reflecting a 20% increase over five years.

Overall, the North American medical cannabis pre-roll market is characterized by robust growth, product innovation, and evolving consumer preferences, positioning it as a dynamic segment within the broader cannabis industry.